Christopher G. Hayes

Companies

• Verrica Pharmaceuticals Inc.General counsel Mar 3, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VPVerrica Pharmaceuticals Inc. VRCA176,458 shares²$672.3K at $3.81Mar 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 17, 2025Sold 4,315 shares at $0.65 of Verrica Pharmaceuticals Inc.²
• Aug 27, 2024Sold 9,530 shares at $2.46 of Verrica Pharmaceuticals Inc.³
• Aug 26, 2024Sold 26,183 shares at $2.66 of Verrica Pharmaceuticals Inc.³
• Jul 23, 2024Sold 91 shares at $6.98 of Verrica Pharmaceuticals Inc.⁴
• Jul 22, 2024Sold 21,649 shares at $7.06 of Verrica Pharmaceuticals Inc.⁴
• Mar 15, 2024Granted 40,000 shares of Verrica Pharmaceuticals Inc.⁵
• Nov 15, 2023Sold 11,558 shares at $2.97 of Verrica Pharmaceuticals Inc.⁶
• Nov 14, 2023Sold 22,141 shares at $2.93 of Verrica Pharmaceuticals Inc.⁶
• Aug 24, 2023Granted 75,000 shares of Verrica Pharmaceuticals Inc.⁷
• Aug 24, 2023Granted 150,000 shares of Verrica Pharmaceuticals Inc.⁸
• Jul 24, 2023Sold 33,789 shares at $4.83 of Verrica Pharmaceuticals Inc.⁹
• Jul 21, 2023Granted 100,000 shares of Verrica Pharmaceuticals Inc.⁹
• Jul 11, 2022Bought 7,500 shares at $3.40 of Verrica Pharmaceuticals Inc.¹⁰
• Jul 5, 2022Bought 5,714 shares at $2.10 of Verrica Pharmaceuticals Inc.¹¹